Raymond C. Bergan - Publications

Affiliations: 
Integrated Graduate Program in the Life Sciences Northwestern University, Evanston, IL 
Area:
Biochemistry, Oncology, General Biophysics

37 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2015 Roy HK, Turzhitsky V, Wali R, Radosevich AJ, Jovanovic B, Della'Zanna G, Umar A, Rubin DT, Goldberg MJ, Bianchi L, De La Cruz M, Bogojevic A, Helenowski IB, Rodriguez L, Chatterton R, ... ... Bergan RC, et al. Spectral biomarkers for chemoprevention of colonic neoplasia: a placebo-controlled double-blinded trial with aspirin. Gut. PMID 26503631 DOI: 10.1136/gutjnl-2015-309996  0.6
2015 Xiao X, Liu Z, Wang R, Wang J, Zhang S, Cai X, Wu K, Bergan RC, Xu L, Fan D. Genistein suppresses FLT4 and inhibits human colorectal cancer metastasis. Oncotarget. 6: 3225-39. PMID 25605009  0.48
2014 Pavese JM, Ogden IM, Voll EA, Huang X, Xu L, Jovanovic B, Bergan RC. Mitogen-activated protein kinase kinase 4 (MAP2K4) promotes human prostate cancer metastasis. Plos One. 9: e102289. PMID 25019290 DOI: 10.1371/journal.pone.0102289  1
2014 Pavese JM, Bergan RC. Circulating tumor cells exhibit a biologically aggressive cancer phenotype accompanied by selective resistance to chemotherapy. Cancer Letters. 352: 179-86. PMID 25016063 DOI: 10.1016/j.canlet.2014.06.012  1
2014 Pavese JM, Krishna SN, Bergan RC. Genistein inhibits human prostate cancer cell detachment, invasion, and metastasis. The American Journal of Clinical Nutrition. 100: 431S-6S. PMID 24871471 DOI: 10.3945/ajcn.113.071290  1
2014 Voll EA, Ogden IM, Pavese JM, Huang X, Xu L, Jovanovic BD, Bergan RC. Heat shock protein 27 regulates human prostate cancer cell motility and metastatic progression. Oncotarget. 5: 2648-63. PMID 24798191 DOI: 10.18632/oncotarget.1917  1
2014 Adams DL, Martin SS, Alpaugh RK, Charpentier M, Tsai S, Bergan RC, Ogden IM, Catalona W, Chumsri S, Tang CM, Cristofanilli M. Circulating giant macrophages as a potential biomarker of solid tumors. Proceedings of the National Academy of Sciences of the United States of America. 111: 3514-9. PMID 24550495 DOI: 10.1073/pnas.1320198111  0.6
2014 Krishna SN, Bergan RC. Therapeutic modulation of prostate cancer metastasis. Future Medicinal Chemistry. 6: 223-39. PMID 24467245 DOI: 10.4155/fmc.13.201  0.96
2013 Krishna SN, Luan CH, Mishra RK, Xu L, Scheidt KA, Anderson WF, Bergan RC. A fluorescence-based thermal shift assay identifies inhibitors of mitogen activated protein kinase kinase 4. Plos One. 8: e81504. PMID 24339940 DOI: 10.1371/journal.pone.0081504  0.6
2013 Pavese J, Ogden IM, Bergan RC. An orthotopic murine model of human prostate cancer metastasis. Journal of Visualized Experiments : Jove. e50873. PMID 24084571 DOI: 10.3791/50873  0.48
2013 Breen MJ, Moran DM, Liu W, Huang X, Vary CP, Bergan RC. Endoglin-mediated suppression of prostate cancer invasion is regulated by activin and bone morphogenetic protein type II receptors. Plos One. 8: e72407. PMID 23967299 DOI: 10.1371/journal.pone.0072407  0.48
2013 Wong SJ, Campbell B, Massey B, Lynch DP, Cohen EE, Blair E, Selle R, Shklovskaya J, Jovanovic BD, Skripkauskas S, Dew A, Kulesza P, Parimi V, Bergan RC, Szabo E. A phase I trial of aminolevulinic acid-photodynamic therapy for treatment of oral leukoplakia. Oral Oncology. 49: 970-6. PMID 23845699 DOI: 10.1016/j.oraloncology.2013.05.011  0.6
2013 Light SH, Krishna SN, Bergan RC, Lavie A, Anderson WF. Crystal structure of a type II dehydroquinate dehydratase-like protein from Bifidobacterium longum. Journal of Structural and Functional Genomics. 14: 25-30. PMID 23539270 DOI: 10.1007/s10969-013-9149-7  0.6
2012 Khan SA, Chatterton RT, Michel N, Bryk M, Lee O, Ivancic D, Heinz R, Zalles CM, Helenowski IB, Jovanovic BD, Franke AA, Bosland MC, Wang J, Hansen NM, Bethke KP, ... ... Bergan RC, et al. Soy isoflavone supplementation for breast cancer risk reduction: A randomized phase ii trial Cancer Prevention Research. 5: 309-319. PMID 22307566 DOI: 10.1158/1940-6207.CAPR-11-0251  0.6
2011 Xu L, Wang SS, Healey MA, Faupel-Badger JM, Wilken JA, Battaglia T, Szabo E, Mao JT, Bergan RC. The Ninth Annual American Association of cancer research international conference on frontiers in cancer prevention research. Cancer Prevention Research (Philadelphia, Pa.). 4: 616-21. PMID 21464034 DOI: 10.1158/1940-6207.CAPR-11-0018  0.6
2011 Romero D, O'Neill C, Terzic A, Contois L, Young K, Conley BA, Bergan RC, Brooks PC, Vary CP. Endoglin regulates cancer-stromal cell interactions in prostate tumors. Cancer Research. 71: 3482-93. PMID 21444673 DOI: 10.1158/0008-5472.CAN-10-2665  0.4
2011 Lakshman M, Huang X, Ananthanarayanan V, Jovanovic B, Liu Y, Craft CS, Romero D, Vary CP, Bergan RC. Endoglin suppresses human prostate cancer metastasis. Clinical & Experimental Metastasis. 28: 39-53. PMID 20981476 DOI: 10.1007/s10585-010-9356-6  0.48
2010 Farmer RL, Biddle MM, Nibbs AE, Huang X, Bergan RC, Scheidt KA. Concise syntheses of the abyssinones and discovery of new inhibitors of prostate cancer and MMP-2 expression. Acs Medicinal Chemistry Letters. 1: 400-405. PMID 21116437 DOI: 10.1021/ml100110x  0.6
2010 Pavese JM, Farmer RL, Bergan RC. Inhibition of cancer cell invasion and metastasis by genistein. Cancer Metastasis Reviews. 29: 465-82. PMID 20730632 DOI: 10.1007/s10555-010-9238-z  0.6
2010 Romero D, Terzic A, Conley BA, Craft CS, Jovanovic B, Bergan RC, Vary CP. Endoglin phosphorylation by ALK2 contributes to the regulation of prostate cancer cell migration. Carcinogenesis. 31: 359-66. PMID 19736306 DOI: 10.1093/carcin/bgp217  0.48
2009 Xu L, Ding Y, Catalona WJ, Yang XJ, Anderson WF, Jovanovic B, Wellman K, Killmer J, Huang X, Scheidt KA, Montgomery RB, Bergan RC. MEK4 function, genistein treatment, and invasion of human prostate cancer cells. Journal of the National Cancer Institute. 101: 1141-55. PMID 19638505 DOI: 10.1093/jnci/djp227  0.6
2008 Paunesku T, Ke T, Dharmakumar R, Mascheri N, Wu A, Lai B, Vogt S, Maser J, Thurn K, Szolc-Kowalska B, Larson A, Bergan RC, Omary R, Li D, Lu ZR, et al. Gadolinium-conjugated TiO2-DNA oligonucleotide nanoconjugates show prolonged intracellular retention period and T1-weighted contrast enhancement in magnetic resonance images. Nanomedicine : Nanotechnology, Biology, and Medicine. 4: 201-7. PMID 18567541 DOI: 10.1016/j.nano.2008.04.004  0.6
2008 Lakshman M, Xu L, Ananthanarayanan V, Cooper J, Takimoto CH, Helenowski I, Pelling JC, Bergan RC. Dietary genistein inhibits metastasis of human prostate cancer in mice. Cancer Research. 68: 2024-32. PMID 18339885 DOI: 10.1158/0008-5472.CAN-07-1246  0.48
2008 Craft CS, Xu L, Romero D, Vary CP, Bergan RC. Genistein induces phenotypic reversion of endoglin deficiency in human prostate cancer cells. Molecular Pharmacology. 73: 235-42. PMID 17951357 DOI: 10.1124/mol.107.038935  0.48
2007 Ding Y, Xu L, Jovanovic BD, Helenowski IB, Kelly DL, Catalona WJ, Yang XJ, Pins M, Bergan RC. The methodology used to measure differential gene expression affects the outcome. Journal of Biomolecular Techniques : Jbt. 18: 321-30. PMID 18166675  0.48
2007 Kim YL, Jacobs DR, Gross MD, Bergan RC, Gann PH, Liu K, Gapstur SM. Associations of serum carotenoid levels with serum insulin-like growth factor-i and insulin-like growth factor binding protein-3 levels in black men and white men. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 16: 2781-3. PMID 18086788 DOI: 10.1158/1055-9965.EPI-07-0637  0.6
2007 Craft CS, Romero D, Vary CP, Bergan RC. Endoglin inhibits prostate cancer motility via activation of the ALK2-Smad1 pathway. Oncogene. 26: 7240-50. PMID 17496924 DOI: 10.1038/sj.onc.1210533  0.4
2006 Xu L, Bergan RC. Genistein inhibits matrix metalloproteinase type 2 activation and prostate cancer cell invasion by blocking the transforming growth factor beta-mediated activation of mitogen-activated protein kinase-activated protein kinase 2-27-kDa heat shock protein pathway. Molecular Pharmacology. 70: 869-77. PMID 16772519 DOI: 10.1124/mol.106.023861  0.48
2006 Eklund J, Kozloff M, Vlamakis J, Starr A, Mariott M, Gallot L, Jovanovic B, Schilder L, Robin E, Pins M, Bergan RC. Phase II study of mitoxantrone and ketoconazole for hormone-refractory prostate cancer. Cancer. 106: 2459-65. PMID 16615097 DOI: 10.1002/cncr.21880  0.6
2005 Simpson L, He X, Pins M, Huang X, Campbell SC, Yang XJ, Perlman EJ, Bergan RC. Renal medullary carcinoma and ABL gene amplification. The Journal of Urology. 173: 1883-8. PMID 15879768 DOI: 10.1097/01.ju.0000158448.56888.09  0.48
2005 Huang X, Chen S, Xu L, Liu Y, Deb DK, Platanias LC, Bergan RC. Genistein inhibits p38 map kinase activation, matrix metalloproteinase type 2, and cell invasion in human prostate epithelial cells. Cancer Research. 65: 3470-8. PMID 15833883 DOI: 10.1158/0008-5472.CAN-04-2807  0.48
2005 Kelley MJ, Glaser EM, Herndon JE, Becker F, Bhagat R, Zhang YJ, Santella RM, Carmella SG, Hecht SS, Gallot L, Schilder L, Crowell JA, Perloff M, Folz RJ, Bergan RC. Safety and efficacy of weekly oral oltipraz in chronic smokers. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 14: 892-9. PMID 15824161 DOI: 10.1158/1055-9965.EPI-04-0585  0.6
2003 Takimoto CH, Glover K, Huang X, Hayes SA, Gallot L, Quinn M, Jovanovic BD, Shapiro A, Hernandez L, Goetz A, Llorens V, Lieberman R, Crowell JA, Poisson BA, Bergan RC. Phase I pharmacokinetic and pharmacodynamic analysis of unconjugated soy isoflavones administered to individuals with cancer. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 12: 1213-21. PMID 14652284  0.6
2003 Hayes SA, Huang X, Kambhampati S, Platanias LC, Bergan RC. p38 MAP kinase modulates Smad-dependent changes in human prostate cell adhesion. Oncogene. 22: 4841-50. PMID 12894225 DOI: 10.1038/sj.onc.1206730  0.6
2002 Jovanovic BD, Huang S, Liu Y, Naguib KN, Bergan RC. An analysis of gene array data related to cell adhesion and prostate cancer. Cancer Treatment and Research. 113: 91-111. PMID 12613352  0.6
2002 Jovanovic BD, Bergan RC, Kibbe WA. Some aspects of analysis of gene array data. Cancer Treatment and Research. 113: 71-89. PMID 12613351  0.48
2002 Liu Y, Jovanovic B, Pins M, Lee C, Bergan RC. Over expression of endoglin in human prostate cancer suppresses cell detachment, migration and invasion. Oncogene. 21: 8272-81. PMID 12447690 DOI: 10.1038/sj.onc.1206117  0.48
Show low-probability matches.